Trial · NCT02065791
Adverse events1,504
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 1,504
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gastroenteritis | Infections and infestations | Placebo | 51 | 2,197 | |
| other | Gastroenteritis | Infections and infestations | Canagliflozin 100 mg | 49 | 2,200 | |
| other | Influenza | Infections and infestations | Placebo | 88 | 2,197 | |
| other | Influenza | Infections and infestations | Canagliflozin 100 mg | 87 | 2,200 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 133 | 2,197 | |
| other | Nasopharyngitis | Infections and infestations | Canagliflozin 100 mg | 130 | 2,200 | |
| other | Onychomycosis | Infections and infestations | Placebo | 33 | 2,197 | |
| other | Onychomycosis | Infections and infestations | Canagliflozin 100 mg | 45 | 2,200 | |
| other | Pneumonia | Infections and infestations | Placebo | 52 | 2,197 | |
| other | Pneumonia | Infections and infestations | Canagliflozin 100 mg | 41 | 2,200 | |
| other | Respiratory Tract Infection | Infections and infestations | Placebo | 44 | 2,197 | |
| other | Respiratory Tract Infection | Infections and infestations | Canagliflozin 100 mg | 19 | 2,200 | |
| other | Upper Respiratory Tract Infection | Infections and infestations | Placebo | 117 | 2,197 | |
| other | Upper Respiratory Tract Infection | Infections and infestations | Canagliflozin 100 mg | 90 | 2,200 | |
| other | Urinary Tract Infection | Infections and infestations | Placebo | 185 | 2,197 | |
| other | Urinary Tract Infection | Infections and infestations | Canagliflozin 100 mg | 202 | 2,200 | |
| other | Limb Injury | Injury, poisoning and procedural complications | Placebo | 45 | 2,197 | |
| other | Limb Injury | Injury, poisoning and procedural complications | Canagliflozin 100 mg | 43 | 2,200 | |
| other | Blood Creatinine Increased | Investigations | Placebo | 185 | 2,197 | |
| other | Blood Creatinine Increased | Investigations | Canagliflozin 100 mg | 140 | 2,200 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02065791/events?page=2